Tumor lysis syndrome: A clinical review

doi:10.5492/wjccm.v4.i2.130

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15498)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

1605

WORD

479

HTML

10155

Figures (1-1)

236

Tables (1-2)

441

Sum=12916

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1135

Download

1447

Sum=2582

May 4, 2015 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (92)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Crit Care Med. May 4, 2015; 4(2): 130-138
Published online May 4, 2015. doi: 10.5492/wjccm.v4.i2.130

Full Size Figure Download Figure

Figure 1 Purine metabolism and sites of action of allopurinol, febuxostat and rasburicase.

Citation: Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A clinical review. World J Crit Care Med 2015; 4(2): 130-138
URL: https://www.wjgnet.com/2220-3141/full/v4/i2/130.htm
DOI: https://dx.doi.org/10.5492/wjccm.v4.i2.130